These compounds, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess different chemical structures leading to their varying pharmacological functions. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, is readily recognized via its molecular formula – C14H15N6O4·H2SO4 – and characteristic radiant properties observed in techniques such as mass spectrometry and infrared assessment. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor inhibitor, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for total identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate tumor treatment, can be verified through its specific mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) spectroscopic data, ensuring its correct chemical characterization.
Directory: Abacavir Disulfate Sulfate (CAS 188062-50-2) & Associated Materials
Explore a extensive listing detailing Abacavir Sulfate, identified by CAS number 188062-50-2, and a variety of connected substances. We supply includes multiple levels to meet particular research and creation needs. You'll detailed data including chemical information and existing packaging options. Furthermore, investigate the array of structurally cognate substances that may be beneficial in the latest project. This directory is designed to assist effective procurement of premium chemical ingredients.
Chemical Index: Abarelex and Abiraterone Acetate Chemical Abstract Service Identifiers
For scientists and drug professionals requiring precise drug identification, accurate CAS codes are essential. Specifically, abarelix, a GnRH-releasing hormone agonist used in treating prostate cancer, is designated the CAS code 65572-21-8. Furthermore, abiraterone acetate, a significant medication in prostate tumors, carries the Registry code 389292-17-3. Careful documentation and validation of these Registry numbers are critical to ensure accurate substance identification and related operations. Such numbers are publicly obtainable through different chemical resources. Frequently check recognized references for the latest details.
Pharmaceutical Components: Abacavir Sulfate , , Abiraterone Acetate, Chemical Abstracts Service Identifiers
The recognition of key pharmaceutical components often relies on precise chemical designations. Notably, this article succinctly covers three important cases: Abacavir, a nucleoside reverse polymerase inhibitor; Abarelix, a hormone antagonist; and Abiraterone, utilized in cancer treatment. These molecule is linked with a unique Chemical Abstracts Service number, supplying AMTOLMETIN GUACIL 87344-06-7 a standardized method for identifying data and ensuring precise reporting within the scientific community. Consult the respective repositories for full listings and connected data.
CAS Registry Number Database: Details for Abacavir Sulfate, Abarelix, Abiraterone Acetate
The comprehensive Chemical Abstracts Service (CAS) database is an essential resource for scientists and pharmaceutical professionals alike. This piece briefly outlines data pertaining to three significant therapeutic compounds: Abacavir Sulfate Salt, a drug used to combat HIV; Abarelix Acetate, a gonadotropin-releasing hormone (GnRH) receptor antagonist utilized in therapy; and Abiraterone Acetate Salt, a potent medication used in the management of metastatic aggressive cancer. Locating the precise CAS identification for each compound allows for reliable identification and promotes precise scientific searching. These distinct identifiers are vital for data accuracy and standardized documentation across the field.
Leveraging API Substance Data: Compound Identification with Chemical Abstracts Service Numbers
Accurate item identification is paramount in the material industry, and Application Programming Interface chemical data provides a robust solution. Specifically, Chemical Abstracts Service numbers act as individual codes for substance substances, enabling seamless consolidation with repositories and frameworks. This approach also bolsters information quality but likewise accelerates processes related to research, procurement, and regulatory submission. Moreover, obtaining this details via an Application Programming Interface promotes efficiency and lessens the risk for human oversight.